Stereotaxis Announces First GenesisX Robotic System Order

Core Insights - Stereotaxis has received its first order for the GenesisX robotic system, marking a significant milestone towards its commercial launch [1][2] - The GenesisX system enhances the accessibility of Robotic Magnetic Navigation in endovascular surgery, featuring a compact design and requiring no structural anchoring [2][3] - The company aims to obtain regulatory approvals for GenesisX and compatible catheters in both Europe and the US during 2025 [3] Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular interventions, focusing on the development of robotic systems and solutions to improve patient care [4] - The technology has been utilized to treat over 150,000 patients globally, demonstrating its impact in the healthcare sector [4]